Comment on: "Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective''

被引：0
|
作者：
Liedgens, Hiltrud [1 ]
Henske, Rainer [1 ]
机构：
[1] Grunenthal GmbH, D-52099 Aachen, Germany
来源：
APPLIED HEALTH ECONOMICS AND HEALTH POLICY | 2013年 / 11卷 / 05期
关键词：
D O I：
10.1007/s40258-013-0048-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：553 / 554
页数：2
相关论文
共 50 条
  • [21] Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis
    Sun, Xueshan
    Zhen, Xuemei
    Hu, Xiaoqian
    Li, Yuanyuan
    Gu, Shuyan
    Gu, Yuxuan
    Zhao, Zixuan
    Yang, Wei
    Dong, Hengjin
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
  • [22] COST-UTILITY ANALYSIS OF ALEMTUZUMAB VERSUS SUBCUTANEOUS INTERFERON BETA-1A FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS: US PAYER PERSPECTIVE
    Smith, A.
    Hashemi, L.
    Wandstrat, T.
    VALUE IN HEALTH, 2017, 20 (05) : A193 - A193
  • [23] Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
    Sun, Xueshan
    Zhen, Xuemei
    Hu, Xiaoqian
    Li, Yuanyuan
    Gu, ShuYan
    Gu, Yuxuan
    Zhao, Zixuan
    Yang, Wei
    Dong, Hengjin
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2021, 19 (01)
  • [24] A COST-UTILITY ANALYSIS COMPARING A CLINICAL DECISION SUPPORT SOFTWARE TO PRESCRIBER DECISION ALONE FOR DRUG-DRUG INTERACTIONS FROM AN US PAYER PERSPECTIVE
    Gomez-Lumbreras, A.
    Zapata, Villa L.
    Akibova, G.
    Malone, D. C.
    VALUE IN HEALTH, 2023, 26 (06) : S75 - S75
  • [25] Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
    Xueshan Sun
    Xuemei Zhen
    Xiaoqian Hu
    Yuanyuan Li
    ShuYan Gu
    Yuxuan Gu
    Zixuan Zhao
    Wei Yang
    Hengjin Dong
    Cost Effectiveness and Resource Allocation, 19
  • [26] COST-UTILITY ANALYSIS AND COST-MINIMISATION ANALYSIS OF SABRIL® (VIGABATRIN) IN DRUG-RESISTANT EPILEPSY FROM PAYER'S PERSPECTIVE IN POLAND
    Kawalec, P.
    Holko, P.
    Lis, J.
    Glasek, M.
    VALUE IN HEALTH, 2012, 15 (07) : A553 - A553
  • [27] Cost-utility of cochlear implants a societal perspective analysis
    Barlev, A
    Hay, JW
    VALUE IN HEALTH, 2004, 7 (03) : 259 - 259
  • [28] Cost-Utility of Cognitive Behavioral Therapy for Low Back Pain From the Commercial Payer Perspective
    Norton, Giulia
    McDonough, Christine M.
    Cabral, Howard
    Shwartz, Michael
    Burgess, James F.
    SPINE, 2015, 40 (10) : 725 - 733
  • [29] Cost-utility analysis
    Brown, GC
    Brown, MM
    Sharma, S
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 625 - 626
  • [30] COST-UTILITY ANALYSIS
    NICHOLLS, A
    BRITISH MEDICAL JOURNAL, 1993, 307 (6913): : 1213 - 1213
12345